Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

"LUT014 0.1% gel provides statistically significant benefit over placebo gel for the treatment of acneiform rash associated with cetuximab (Erbitux) or panitumumab (Vectibix) therapy for patients ...

Anti-EGFR therapies, such as cetuximab and panitumumab, are a cornerstone of treatment for many cancers, including colorectal cancer. However, they often cause an acneiform rash that frequently ...

“Of those patients with the rash, two thirds had a dose impact on ... colorectal cancer who were receiving cetuximab or panitumumab and had developed grade 2 or noninfected grade 3 acneiform ...

Anti-EGFR therapies, such as cetuximab and panitumumab, are a cornerstone of treatment for many cancers, including colorectal cancer. However, they often cause an acneiform rash that frequently ...

Anti-EGFR therapies, such as cetuximab and panitumumab, are a cornerstone of treatment for many cancers, including colorectal cancer. However, they often cause an acneiform rash that frequently ...

“This rash can have a high impact on patients ... such as cetuximab and panitumumab. However, EGFR inhibition blocks the MAPK pathway, disrupting normal skin cell function and triggering ...